XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation - Stock Options and Significant Valuation Assumptions (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Jun. 25, 2022
Jun. 26, 2021
Options    
Stock Options    
Outstanding at the beginning of period 728,079  
Granted 86,189 0
Exercised (11,212)  
Outstanding at the end of period 803,056  
Vested and expected to vest after end of period 803,056  
Exercisable at end of period 293,267  
Grant Date Weighted-Average Exercise Price    
Outstanding at the beginning of period $ 23.44  
Granted 86.96  
Exercise price (in dollars per share) 22.03  
Outstanding at the end of period 30.28  
Vested and expected to vest at end of period 30.28  
Exercisable at end of period $ 19.49  
Weighted Average Remaining Contractual Life    
Weighted average remaining contractual life, awards outstanding 6 years 7 months 6 days  
Weighted average remaining contractual life, awards vested and expected to vest 6 years 7 months 6 days  
Weighted average remaining contractual life, awards exercisable 5 years  
Aggregate Intrinsic Value    
Aggregate intrinsic value, awards exercised $ 610  
Aggregate intrinsic value, awards outstanding 39,189  
Aggregate intrinsic value, awards vested and expected to vest 39,189  
Aggregate intrinsic value, awards exercisable $ 17,196  
CEO | 2020 Plan    
Assumptions used    
Stock price (in dollars per share) $ 86.96  
Exercise price (in dollars per share) $ 86.96  
Expected option term 6 years 6 months  
Expected volatility factor 65.90%  
Risk-free interest rate 2.80%  
Expected annual dividend yield 0.00%  
Stock Options    
Granted 86,189